Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - capivasertibum - comprimés pelliculés - capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - le cancer du sein - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - capivasertibum - comprimés pelliculés - capivasertibum 200 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 2.28 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - le cancer du sein - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - exenatidum - poudre et solvant pour la préparation d'un dépôt de suspension injectable - exenatidum 2 mg, le poly(lactidum-co-glycolidum) 50/50, le sucre, carmellosum natricum, natrii chloridum, polysorbatum 20, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii hydroxidum à un ph de l'eau à iniectabilia q.s. pour la suspension, pour dosi corresp. sodium 4.39 mg. - antidiabetikum - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - poudre pour inhalation - budesonidum 200 µg pro dosi, doses pro vase 200. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - poudre pour inhalation - budesonidum 100 µg pro dosi, les doses pro vase 200. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - poudre pour inhalation - budesonidum 400 µg pro dosi, doses pro vase 50. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - suspension - budesonidum 0.25 mg, dinatrii edetas, natrii chloridum, polysorbatum 80, acidum citricum, natrii citras dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - suspension - budesonidum 0.5 mg, dinatrii edetas, natrii chloridum, polysorbatum 80, acidum citricum, natrii citras dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum - suspension - budesonidum 0.125 mg, dinatrii edetas, natrii chloridum, polysorbatum 80, acidum citricum, natrii citras dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - maladies respiratoires obstructives - synthetika

Sveits - fransk - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - budesonidum, formoteroli fumaras dihydricus - poudre pour inhalation - budesonidum 100 µg, formoteroli fumaras dihydricus 6 µg, lactosum monohydricum, ad pulverem pro dosi. - antiasthmatikum, la bpco - synthetika